Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luminal Fructose Kinetics in Healthy Volunteers and MASLD/MASH Participants
NL-OMON56753Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of omeprazole in metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) (2 arms), sponsored by Amsterdam University Medical Center. Started Sep 2024; status: recruiting.
02
Drugs
omeprazole
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on NL-OMON56753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56753.